SANOFICONR · Healthcare · Drug Manufacturers - General
Composite scorecard: 54/100 — Quality 76 · Valuation 46 · Momentum 14
| Share price | ₹4,528.80 |
| Market cap | ₹10,532 Cr |
| P/E ratio | 40.8 |
| P/B ratio | 27.4 |
| ROCE | 77.0% |
| Dividend yield | 1.64% |
| Book value | ₹166.71 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2025 | ₹878 Cr | ₹240 Cr | 33.9% |
| 2024 | ₹716 Cr | ₹181 Cr | 37.2% |
| 2023 | ₹544 Cr | ₹165 Cr | 39.9% |
Sanofi Consumer Healthcare India Limited operates as a fast-moving consumer healthcare company in India. The company offers products in the allergy, physical wellness, and pain care segments under Allegra, Combiflam, Avil, DePURA, Festal, and other brand names through distributors, wholesalers, government institutions and hospitals, pharmacy chains, and e-commerce platforms. The company was incorporated in 2023 and is based in Mumbai, India. Sanofi Consumer Healthcare India Limited operates as a subsidiary of Opella Healthcare Participations B.V.